Demographic diversity of participants in Pfizer sponsored clinical trials in the United States-Reference-Cited by-同舟云学术

Demographic diversity of participants in Pfizer sponsored clinical trials in the United States

Published:2021-07 Issue: Volume:106 Page:106421
ISSN:1551-7144
Container-title:Contemporary Clinical Trials
language:en
Short-container-title:Contemporary Clinical Trials

Author:

Rottas Melinda,Thadeio Peter,Simons Rachel,Houck Raven,Gruben David,Keller David,Scholfield David,Soma Koshika,Corrigan Brian,Schettino Annette,McCann Patrick J.,Hellio Marie-Pierre,Natarajan Kannan,Goodwin Rob,Sewards Judy,Honig Peter,MacKenzie Rod

Publisher

Elsevier BV

Subject

Pharmacology (medical),General Medicine

Reference18 articles.

1. Quantifying patient subpopulation disparities in new drugs and biologics approved between 2007 and 2017;Getz;Ther. Innov. Regul. Sci.,2020

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The value of decentralized clinical trials: Inclusion, accessibility, and innovation;Science;2024-08-23

2. How close are we from achieving demographic diversity in clinical trials? Insights from Singapore;Annals of the Academy of Medicine, Singapore;2024-07-30

3. Demographic diversity of participants in clinical trials conducted in Singapore;Annals of the Academy of Medicine, Singapore;2024-07-30

4. Cognitive Assessment with Cognivue Clarity®: Psychometric Properties and Normative Ranges in a Diverse Population;Journal of Alzheimer's Disease;2024-07-16

5. Impact of Race on the Efficacy and Safety of Tofacitinib in Rheumatoid Arthritis: Post Hoc Analysis of Pooled Clinical Trials;Rheumatology and Therapy;2024-07-03